CareDx, a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, completed the acquisition of MediGO, a health consultant company. Financial terms were not disclosed. "MediGO shares our patient-centric mission to improve the transplant journey and brings a wealth of expertise to CareDx. By leveraging our combined strengths, we will drive operational efficiencies, accelerate innovation, and deliver even greater value to the transplant ecosystem by addressing the serious organ transplant shortage," Reg Seeto, CareDx CEO and President.